Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
US7138501 | NA | Antibodies that immunospecifically bind BLyS |
Mar, 2025
(1 year, 5 months from now) |
Ingredients: BELIMUMAB
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic